# Boehringer Ingelheim inaugurates EUR 70M R&D center in Saint-Priest, France

Boehringer Ingelheim inaugurated an international R&D center of 14,500 m² at its Saint-Priest site, with an investment of EUR 70 million. The center houses 200 employees transferred from Gerland. A production building is under construction with an additional EUR 65 million investment.

- Type: Expansion
- Announced: 2018-10-12
- Where: Saint-Priest, Rhône, France
- Value: $81.0M (70.0M EUR)
- Jobs: 200
- Starts operating: 12 Oct 2018
- Status: completed
- Products: veterinary vaccines, biological products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boehringer Ingelheim](https://endata.com/companies/25171.md)

## Sources

- [leprogres.fr](https://www.leprogres.fr/rhone-69-edition-est-lyonnais/2018/10/14/boehringer-ingelheim-poursuit-son-investissement-dans-l-est-lyonnais), 2018-10-14: "Il continue de s’étendre avec la construction d’un bâtiment de production sur l’arrière de la parcelle."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.